Biblio Discovery — Demo Discovery Service

10 results for "Victoria E. Cook"

Showing 1–10 · 0.55 seconds · RSS

  1. Journal Article

    Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond

    Gilbert T. Chua; Edmond S. Chan; Lianne Soller et al.

    Frontiers in Allergy, Vol. 2 · 2021 · English · DOAJ Scopus

    The coronavirus disease 2019 (COVID-19) pandemic has led to the deprioritization of non-emergency services, such as oral food challenges and the initiation of oral immunotherapy (OIT) for food-allergic children. Recent studies have suggested that home-based peanut OIT could be a safe and effective…

  2. Journal Article

    Beyond first sip: combination of intermittent cow’s milk exposure and atopic dermatitis associated with severe IgE mediated cow’s milk reactions—a retrospective study

    Amy Plessis; Victoria E. Cook; Stephanie C. Erdle et al.

    Allergy, Asthma & Clinical Immunology, Vol. 22 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background The prevalence of IgE-mediated cow’s milk allergy in Canada has been increasing and is recognized as the leading cause of fatal anaphylaxis in school aged children. Experts are unable to predict which individuals will have spontaneous resolution of cow’s milk allergy and who…

  3. Journal Article

    Using the canadian egg ladder in children with food protein-induced enterocolitis syndrome: a case series

    Linlei Ye; Tiffany Wong; Elana Lavine et al.

    Allergy, Asthma & Clinical Immunology, Vol. 19 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Current management of food protein-induced enterocolitis syndrome (FPIES) involves strict avoidance of the offending food for 12–18 months, followed by oral food challenge (OFC) under physician supervision. OFCs are resource-intensive and there is a lack of a universal…

  4. Journal Article

    Non-immunoglobulin E-mediated food allergy

    Victoria E. Cook; Lori A. Connors; Timothy K. Vander Leek et al.

    Allergy, Asthma & Clinical Immunology, Vol. 20 No. S3 · 2024 · English · DOAJ Scopus

    Abstract Non-immunoglobulin E (IgE)-mediated food allergies are characterized by delayed gastrointestinal (GI) manifestations that occur after exposure to an inciting food protein; they include food protein-induced allergic proctocolitis (FPIAP), food protein–induced enteropathy (FPE), and food…

  5. Journal Article

    Real-world experience: a retrospective pediatric chart review to determine why patients and caregivers discontinue oral immunotherapy

    Amy A. Plessis; Scott B. Cameron; Rosemary Invik et al.

    Allergy, Asthma & Clinical Immunology, Vol. 20 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background Oral immunotherapy (OIT) is an increasingly utilized management strategy for IgE-mediated food allergy. Despite promising efficacy and effectiveness, there is still a lack of data surrounding the reasons for discontinuation of OIT. The primary reason stated in the literature for…

  6. Journal Article

    Allergic reactions to emerging food allergens in Canadian children

    Lianne Soller; Sebastien La Vieille; Scott B. Cameron et al.

    Allergy, Asthma & Clinical Immunology, Vol. 17 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Most Canadian food allergy data has focused on Health Canada’s priority food allergens. This study describes which non-priority (emerging) food allergens were most commonly reported by Canadian parents and categorized/confirmed by allergists. A secondary aim was to describe severity of…

  7. Journal Article

    Respiratory Presentation of Pediatric Patients in the 2014 Enterovirus D68 Outbreak

    Georgina Martin; Rachel Li; Victoria E. Cook et al.

    Canadian Respiratory Journal, Vol. 2016 · 2016 · English · DOAJ Scopus

    Background. In the fall of 2014, a North American outbreak of enterovirus D68 resulted in a significant number of pediatric hospital admissions for respiratory illness throughout North America. This study characterized the clinical presentation and risk factors for a severe clinical course in…

  8. Journal Article

    Real-world safety and effectiveness analysis of low-dose preschool sesame oral immunotherapy

    Gilbert T. Chua, MBBS; Lianne Soller, PhD; Sandeep Kapur, MD et al.

    Journal of Allergy and Clinical Immunology: Global, Vol. 3 No. 1 · 2024 · English · DOAJ Scopus

    Background: Previous studies support the effectiveness of sesame oral immunotherapy (S-OIT) in patients >4 years old using maintenance doses of 1200 mg protein. However, tahini is often not palatable to children, and high-maintenance doses may not be possible for preschoolers. Objective: We studied…

  9. Journal Article

    Risk factors associated with safety of preschool peanut oral immunotherapy

    Duva Karunakaran, BSc; Edmond S. Chan, MD; Qian Zhang et al.

    Journal of Allergy and Clinical Immunology: Global, Vol. 2 No. 2 · 2023 · English · DOAJ Scopus

    Background: An understanding of how patient characteristics such as age, baseline peanut-specific IgE, and atopic comorbidities may influence potential safety outcomes during peanut oral immunotherapy (P-OIT) could aid in shared decision making between clinicians and patient families. Objective…